News

Centennial celebrations of insulin’s discovery have, with good reason, tended to dwell on progress and innovation in its design and usage. But what about the more basic challenges still faced by so man...

The 57th Annual Meeting of the European Association for the Study of Diabetes (EASD) opens tomorrow. Once again, this year’s conference will be virtual – and there are some new ‘live’...

At the American Diabetes Association (ADA) 81st Scientific Sessions, two fascinating presentations on the evolution of diabetes nutrition therapy revealed how we’ve got to where we are today.

Topline results from the EMPEROR-Preserved Phase 3 trial suggest potential for empagliflozin as a treatment for heart failure with preserved ejection fraction. The as-yet-unpublished findings are due to be p...

As bariatric surgery becomes more popular, we’re finding out more about its safety and outcomes. At the 2021 Diabetes UK Professional Conference, two experts explored its complications and benefits.

Metformin is used in pregnancy but there are still knowledge gaps. Here’s what we do and don’t know…

Healthcare providers need tools to help personalise care for people living with diabetes, so they can achieve better outcomes and quality of life. But as attendees at this year’s Precision Medicine Dia...

With the second COVID-19-era Ramadan now ended, Professor Wasim Hanif presents detailed guidance on supporting people with diabetes to fast safely during a pandemic.

This year marks the second Ramadan carried out under the shadow of the COVID-19 pandemic. It is an event that already comes with additional layers of risk for Muslims with diabetes, as Dr Sarah Ali, consulta...

Awareness among healthcare professionals and the importance of education and discussion with patients were key points in a survey of issues around hypoglycaemia and how to fast safely during Ramadan at the S...

Transplantation conference hears calls for an end to the notion of islet transplantation as experimental therapy, to be dealt with separately from whole pancreas transplantation in national allocation polici...

Links between non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes loomed large at the Paris Hepatology Conference in March, as did the potential use of diabetes treatments to counter the rise of th...

EASD e-Learning’s latest initiative, ‘The long and the short it’, launches today.

Are DCD donors the solution to boosting islet transplantations?

The importance of involving patients in their own care and ensuring that their voices are heard was the theme of three presentations within the Patients Inclusion Initiative, a joint EPITA/EDTCO/ETAHP sympos...

A study published last May in the New England Journal of Medicine (NEJM), which described morphological and molecular changes in the lungs of people who died from COVID-19, is now cited as a turning point in...

Listening to our learners is at the forefront of ensuring the EASD e-Learning programme is up to date, evidence based and meets the needs of our learners. It is also important that you know your feedback is ...

COVID-19 has had a devastating impact on islet and pancreas transplantation, with many centres suspending their programmes and major reductions in organ retrievals. On day one of the 11th European Pancreas a...

This week the EASD e-Learning platform is launching a new section on its site. Called ‘Horizons’, the section aims to be a more user-friendly central place where our learners can get diabete...

Should type 2 diabetes medications with proven cardiovascular benefits be used to prevent atherosclerotic cardiovascular disease in type 1 diabetes?

The association between severe COVID-19 and obesity is well established, but how exactly does obesity fit into the COVID-19 picture?